Full Press Release Details
Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome.
IONS
Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome
Key Takeaway: Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome